Medical specialists from Japan tagged as investigators in clinical trials studying Lung Neoplasms

Total 60 results

Akihito Kubo, MD
Seen in:
- Osaka, Sakai, NHO Kinki-Chuo Chest Medical Center
Trials:
- NCT00546130 (Principal Investigator)
Conditions:
- Small Cell Lung Cancer
Eisaku Miyauchi
Seen in:
- Aoba-ku, Sendai, Tohoku University School of Medicine
Trials:
- NCT03811002 (Principal Investigator)
Conditions:
Haruhiro Saito
Seen in:
- Yokohama-shi, Kanagawa Cancer Center
Trials:
- NCT05882734 (Principal Investigator)
Conditions:
- Non-Small Cell Lung Cancer
Haruko Daga
Seen in:
- Osaka, Osaka City General Hospital
Trials:
- NCT03906331 (Principal Investigator)
- NCT03157128 (Principal Investigator)
- NCT05973773 (Principal Investigator)
Conditions:
Haruyasu Murakami
Seen in:
- Shizuoka, Shizuoka Cancer Center
- Shizuoka-Ken, Sunto-gun, Shizuoka Cancer Center
Trials:
- NCT05765734 (Principal Investigator)
- NCT04036682 (Principal Investigator)
Conditions:
Haruyuki Ishii
Seen in:
- Tokyo, Mitaka-shi, Kyorin University Hospital
Trials:
- NCT03811002 (Principal Investigator)
Conditions:
Haurko Daga
Seen in:
- Osaka, Osaka City General Hospital
Trials:
- NCT04036682 (Principal Investigator)
Conditions:
- Non Small Cell Lung Cancer;
- EGFR Exon 20 Mutation
Hidenobu Ishii
Seen in:
- Kurume-shi, Kurume University Hospital
Trials:
- NCT05882734 (Principal Investigator)
Conditions:
- Non-Small Cell Lung Cancer
Hidetoshi Hayashi
Seen in:
- Osaka, GSK Investigational Site
Trials:
- NCT05565378 (Principal Investigator)
Conditions:
- Lung Cancer, Non-Small Cell
Hirishige Yoshioka, MD
Seen in:
- Okayama, Kurashiki, Kurashiki Central Hospital
Trials:
- NCT00546130 (Principal Investigator)
Conditions:
- Small Cell Lung Cancer
Hiroaki Momi
Seen in:
- Kagoshima, Kagoshima City, Kagoshima City Hospital
Trials:
- NCT03811002 (Principal Investigator)
Conditions:
Hirohisa Toga, MD
Seen in:
- Ishikawa, Uchinada, Kanazawa Medical University Hospital
Trials:
- NCT00546130 (Principal Investigator)
Conditions:
- Small Cell Lung Cancer
Hirohito Tada, MD
Seen in:
- Osaka, Osaka City General Hospital
Trials:
- NCT00139971 (Principal Investigator)
Conditions:
- Lung Cancer
Hiroshi Tanaka, MD, PhD
Seen in:
- Niigata, Niigata Cancer Center
Trials:
- NCT04036682 (Principal Investigator)
Conditions:
- Non Small Cell Lung Cancer;
- EGFR Exon 20 Mutation
Hirotsugu Kenmotsu
Seen in:
- Shizuoka, Nagaizumi, Shizuoka Cancer Center
- Shizuoka, Nagaizumi, Tominaga Hospital
- Shizuoka, Nagaizumi-cho,Sunto-gun, Shizuoka Cancer Center
- Shizuoka, Nagaizumi-cho,Sunto-gun, Tominaga Hospital
Trials:
- NCT04819100 (Principal Investigator)
- NCT03157128 (Principal Investigator)
Conditions:
Isamu Okamoto
Seen in:
- Fukuoka, Fukuoka-shi, Kyushu University Hospital
- Fukuoka, GSK Investigational Site
- Fukuoka, Kyushu University Hospital
Trials:
- NCT05207371 (Principal Investigator)
- NCT05565378 (Principal Investigator)
- NCT06119581 (Principal Investigator)
Conditions:
Jun Sakakibara
Seen in:
- Hokkaido, Sapporo, Hokkaido University Hospital
Trials:
- NCT03906331 (Principal Investigator)
- NCT03157128 (Principal Investigator)
Conditions:
Kadoaki Ohashi
Seen in:
- Okayama, Okayama University Hospital
- Okayama, Okayamashi, Okayama University Hospital
Trials:
- NCT03157128 (Principal Investigator)
- NCT05973773 (Principal Investigator)
- NCT06119581 (Principal Investigator)
Conditions:
Kazuo Kasahara, MD
Seen in:
- Ishikawa, Kanazawa, Kanazawa University Hospital
Trials:
- NCT00546130 (Principal Investigator)
Conditions:
- Small Cell Lung Cancer
Keiichi Iwase, MD
Seen in:
- Toyama, Toyama Red Cross Hospital
Trials:
- NCT00546130 (Principal Investigator)
Conditions:
- Small Cell Lung Cancer
Koichi Goto
Seen in:
- Chiba, Kashiwa, National Cancer Center Hospital East
- Chiba-Ken, Kashiwa-shi, National Cancer Center Hospital East
Trials:
- NCT03906331 (Principal Investigator)
- NCT03157128 (Principal Investigator)
- NCT05765734 (Principal Investigator)
Conditions:
Kyoichi Kaira
Seen in:
- Saitama, GSK Investigational Site
- Saitama, Saitama Medical University International Medical Center
Trials:
- NCT03811002 (Principal Investigator)
- NCT05565378 (Principal Investigator)
Conditions:
Makoto Nishio
Seen in:
- Tokyo, Koto, Japanese Foundation for Cancer Research
Trials:
- NCT03157128 (Principal Investigator)
Conditions:
Masahiro Morise
Seen in:
- Aichi, Nagoya, Nagoya University Hospital
Trials:
- NCT03157128 (Principal Investigator)
Conditions:
Masahiro Tsuboi, MD
Seen in:
- Tokyo, Tokyo Medical University Hospital
Trials:
- NCT00546130 (Principal Investigator)
Conditions:
- Small Cell Lung Cancer
Minoru Takada, MD
Seen in:
- Osaka, Sakai, Kinkidaigakuigakubu Sakai Hospital
Trials:
- NCT00546130 (Principal Investigator)
Conditions:
- Small Cell Lung Cancer
Miyako Satouchi
Seen in:
- Hyogo, Akashi, Hyogo Cancer Center
- Hyogo, GSK Investigational Site
Trials:
- NCT03157128 (Principal Investigator)
- NCT05565378 (Principal Investigator)
Conditions:
Nishino Kazumi, MD, PhD
Seen in:
- Osaka, Osaka International Cancer Institute
Trials:
- NCT04036682 (Principal Investigator)
Conditions:
- Non Small Cell Lung Cancer;
- EGFR Exon 20 Mutation
Noboru Hattori
Seen in:
- Hiroshima City, Hiroshima University Hospital
Trials:
- NCT03811002 (Principal Investigator)
Conditions:

Clinical Trials on Lung Neoplasms

UNC Lineberger Comprehensive Cancer Center
Sivan Innovation Ltd.

Completed

Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare® (LC-PRO)

Lung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of Lung

United States
Baptist Health South Florida

Withdrawn

Study of LUNG Stereotactic Adaptive Ablative Radiotherapy (LUNG STAAR)

Lung Cancer | Lung Tumor

United States
Portsmouth Hospitals NHS Trust

Completed

Assessment of Exhaled Breath Condensate Hydrogen Peroxide (EBC H2O2) as Measured Using a New Device (Inflammacheck™) in Patients With Interstitial Lung Disease, Lung Cancer and Healthy Volunteers. (EXHALE 1B)

Lung Cancer | Interstitial Lung Disease

United Kingdom
Oliver Jonas
Massachusetts General Hospital

Completed

Microdevice for Evaluating Drug Response in Site in Lung Lesions

Lung Cancer | Lung Tumor

United States
C. R. Bard

Completed

NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study

Lung Cancer | Lung Tumor

United States
Point Therapeutics

Terminated

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Carcinoma, Non-Small-Cell Lung | Lung Cancer | Neoplasms, Lung | Neoplasms, Pulmonary

United States
Azienda Sanitaria-Universitaria Integrata di Udine

Recruiting

Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions

Lung Diseases | Lung Cancer | Lung Adenocarcinoma | Lung Transplant Rejection | Lung; Node | Lung TB

Italy
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer

Lung Carcinoma | Lung Neoplasm | Malignant Lung Neoplasm

United States
Keimyung University Dongsan Medical Center

Completed

The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease

Lung Cancer | Lung Diseases, Interstitial
University of Utah

Recruiting

The MyLungHealth Study Protocol: Engaging Patients to Enable Interoperable Lung Cancer Decision Support at Scale (MyLungHealth)

Lung Cancer | Lung Neoplasms/Diagnosis

United States

Medical specialists from Japan tagged as investigators in clinical trials studying Lung Neoplasms

Clinical Trials on Lung Neoplasms

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations